過(guò)氧化還原酶2(PRDX2)重組蛋白
Recombinant Peroxiredoxin 2 (PRDX2)
PRP; NKEFB; PRXII; TDPX1; TSA; Thioredoxin-Dependent Peroxide Reductase 1; Thiol-Specific Antioxidant 1; Natural Killer-Enhancing Factor B; Thioredoxin Peroxidase 1; Torin
- 編號(hào)RPF757Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位n/a
- 預(yù)測(cè)分子量-
- 實(shí)際分子量-(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽N-terminal His and GST Tag
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)-
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 960¥ 2400¥ 4800¥ 14400¥ 36000
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
SDS-PAGE圖
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
PBS或其它。
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPF757Hu02 | 過(guò)氧化還原酶2(PRDX2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu03 | 過(guò)氧化還原酶2(PRDX2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu01 | 過(guò)氧化還原酶2(PRDX2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF757Hu01 | 過(guò)氧化還原酶2(PRDX2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAF757Hu03 | 過(guò)氧化還原酶2(PRDX2)多克隆抗體 | WB,IHC |
| PAF757Hu02 | 過(guò)氧化還原酶2(PRDX2)多克隆抗體 | WB; IHC; ICC; IP. |
| FAF757Hu03 | 抗過(guò)氧化還原酶2(PRDX2)多克隆抗體 | Flow cytometry. |
| MAF757Hu23 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB |
| MAF757Hu22 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAF757Hu21 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB |
| MAF757Hu24 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB |
| MAF757Hu25 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAF757Hu26 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAF757Hu27 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAF757Hu28 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAF757Hu29 | 過(guò)氧化還原酶2(PRDX2)單克隆抗體 | WB; IHC; ICC; IP. |
| WEF757Hu | 過(guò)氧化還原酶2(PRDX2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEF757Hu | 過(guò)氧化還原酶2(PRDX2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF757Hu | 過(guò)氧化還原酶2(PRDX2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Free Radical Research | Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress[Pubmed:25564095] |
| PLoS One | Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages[pubmed:27716839] |
| Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription[pubmed:28672924] |
| Oncotarget | Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition[pubmed:29207618] |
| European Journal of Applied Physiology | Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men[Pubmed:29785503] |
| Journal of Applied Physiology | Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight middle-aged men[Pubmed: 30496705] |
| ACS Omega | SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics[34250342] |